Literature DB >> 2990608

Associated chronic lymphocytic leukemia and multiple myeloma: origin from a single clone.

J P Fermand, J M James, P Herait, J C Brouet.   

Abstract

We investigated the clonal relationship of malignant cells in a patient affected with both chronic lymphocytic leukemia (CLL) and multiple myeloma (MM). CLL cells and malignant plasma cells synthesized IgG1 kappa and IgA kappa molecules, respectively; these monoclonal Ig shared idiotypic determinants, providing evidence that a single clonal disease occurred in this patient. Furthermore, when leukemic CLL cells were driven to differentiate in vitro to immunoblasts and plasma cells, a switch from IgG to IgA occurred in a significant percentage of cells that were double producers. These data suggest that, in some circumstances, CLL leukemic B cells may reach a more mature state, leading to the occurrence of clinical MM.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990608

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection.

Authors:  F Fend; L Quintanilla-Martinez; S Kumar; M W Beaty; L Blum; L Sorbara; E S Jaffe; M Raffeld
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Concomitant Presence of Two Distinct Clones of Chronic Lymphocytic Leukemia and Plasma Cell Myeloma in a Patient.

Authors:  Sabina Langer; Meenal Mehta; Amrita Saraf; Aastha Gupta; Keyur Pipliya; Atul Kakar; Manorama Bhargava
Journal:  Indian J Hematol Blood Transfus       Date:  2015-03-01       Impact factor: 0.900

3.  Hypercalcemia, monoclonal protein, and osteolytic bone lesions in chronic lymphocytic leukemia.

Authors:  M Van de Casteele; G E Verhoef; H Demuynck; P Zacheé; M A Boogaerts
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673

4.  Immunoglobulin gene sequence analysis to further assess B-cell origin of multiple myeloma.

Authors:  D D Biggs; P Kraj; J Goldman; L Jefferies; C Carchidi; K Anderson; L E Silberstein
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

5.  Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells.

Authors:  Andrea Cerutti; Hong Zan; Edmund C Kim; Shefali Shah; Elaine J Schattner; András Schaffer; Paolo Casali
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

6.  CLL: Common Leukemia; Uncommon Presentations.

Authors:  Deepesh Lad; Pankaj Malhotra; Neelam Varma; Manupdesh Singh Sachdeva; Ashim Das; Radhika Srinivasan; Amanjit Bal; Alka Khadwal; Gaurav Prakash; Vikas Suri; Savita Kumari; Sanjay Jain; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-24       Impact factor: 0.900

7.  Coexisting multiple myeloma, lymphoma, and non-small cell lung cancer: a case report and review of the literature.

Authors:  Parth Khade; Srinivas Devarakonda
Journal:  Int Med Case Rep J       Date:  2017-11-08

Review 8.  The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches.

Authors:  Pankita H Pandya; Mary E Murray; Karen E Pollok; Jamie L Renbarger
Journal:  J Immunol Res       Date:  2016-12-26       Impact factor: 4.818

9.  Unusual Extramedullary Plasmacytoma: A Rare but Possible Cause of Lymphadenopathy in Chronic Lymphocytic Leukemia.

Authors:  S P Chantepie; Q Cabrera; J B Mear; V Salaun; E Lechapt-Zalcman; M Macro
Journal:  Case Rep Med       Date:  2015-07-07

10.  Development of plasma cell myeloma in a B-cell chronic lymphocytic leukemia patient with chromosome 12 trisomy.

Authors:  Welbert de Oliveira Pereira; Nydia Strachman Bacal; Rodolfo Patussi Correia; Ruth Hissae Kanayama; Elvira Deolinda Veloso; Daniela Borri; Nelson Hamerschlak; Paulo Vidal Campregher
Journal:  BMC Res Notes       Date:  2013-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.